Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04128267 · ClinicalTrials.gov registry record · NA
Central Pain Syndrome in Survivors of Head and Neck Cancer
A NA study, sponsored by Vanderbilt-Ingram Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT04128267: Clinical Trial NA study, sponsored by Vanderbilt-Ingram Cancer Center.
NCT04128267 is a NA study that was terminated before completion, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04128267, a NA study, was terminated before completion, sponsored by Vanderbilt-Ingram Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a cross-sectional pilot study of head and neck cancer survivors who have completed multi-modal treatment to assess and characterize the presence of distinct pain syndromes.
Primary Outcome
MRI scan of brain to measure response to stimulated pressure to thumbnail
Interventions
- DEVICE Magnetic resonance imaging
- OTHER Correlative Studies
- DEVICE IPC-1000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2022-07-21 |
| Phase | NA |
Why NCT04128267 stopped before completion
NCT04128267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Magnetic resonance imaging is the first listed.
NCT04128267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04128267 about?
NCT04128267 is a clinical study titled "Central Pain Syndrome in Survivors of Head and Neck Cancer". This is a cross-sectional pilot study of head and neck cancer survivors who have completed multi-modal treatment to assess and characterize the presence of distinct pain syndromes.
What is the current status of trial NCT04128267?
This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2019-11-04. Estimated completion is 2022-07-21.
What interventions are being tested in trial NCT04128267?
The interventions under investigation include: Magnetic resonance imaging (DEVICE), Correlative Studies (OTHER), IPC-1000 (DEVICE).
Who is sponsoring clinical trial NCT04128267?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04128267's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI